Swiss Archives of Neurology, Psychiatry and Psychotherapy

267 KB

Open AccessBook Review

Polyneuropathie—so überwinden Sie quälende Nervenschmerzen

by EMH Swiss Medical Publishers Ltd.

Swiss Arch. Neurol. Psychiatry Psychother. 2018, 169(6), 193-194; https://doi.org/10.4414/sanp.2018.00582 - 1 Jan 2018

Abstract

Jeder Neurologe, der regelmässig Menschen mit neuromuskulären Erkrankungen sieht, weiss wie quälend die Beschwerden und insbesondere Schmerzen im Rahmen eines Polyneuropathie- Syndroms sein können [...] Full article

267 KB

Open AccessArticle

Siegmund Freud Gesamtausgabe Band 8 bis 10

by EMH Swiss Medical Publishers Ltd.

Swiss Arch. Neurol. Psychiatry Psychother. 2018, 169(6), 193-194; https://doi.org/10.4414/sanp.2018.00577 - 1 Jan 2018

Viewed by 1

Abstract

Mit dem Erscheinen der nächsten drei Bände der Sigmund Freud-Gesamtausgabe (SFG) im letzten und in diesem Jahr geht die Reise durch die Werkbiographie und alle publizierten Texte Freuds weiter [...] Full article

742 KB

Open AccessArticle

Une drogue fictive qui pourtant ressemble aux substances psychoactives dans notre société: Le trouble d’utilisation de substances dans le film Limitless

by Fatima Diouf, Julie Beuret, Daniele Zullino and Gerard Calzada

Swiss Arch. Neurol. Psychiatry Psychother. 2018, 169(6), 192; https://doi.org/10.4414/sanp.2018.00602 - 1 Jan 2018

Viewed by 119

Abstract

Le film Limitless est un thriller américain sorti en 2011 et réalisé par Neil Burger [...] Full article

105 KB

Open AccessArticle

Interview mit Dr. Alphons Beat Schnyder, Inhaber der Beratungsfirma «Meta-Cultura» in Zürich: Psychiatrische Versorgung in der Schweiz und in den «least developed countries»

by Alphons B. Schnyder and Karl Studer

Swiss Arch. Neurol. Psychiatry Psychother. 2018, 169(6), 190-191; https://doi.org/10.4414/sanp.2018.00596 - 1 Jan 2018

Viewed by 75

Abstract

Dr. Alphons Beat Schnyder ist als Betriebswirtschafter, Experte für Unternehmenskultur und Mitglied der Verwaltungsräte des Spitals STS (Simmental-Thun-Saanenland) und der Triaplus (Integrierte Psychiatrie Uri, Schwyz und Zug) sowie als Referent im Masterprogramm «Health Management» der Hochschule für Wirtschaft ausgewiesener Kenner des Schweizerischen Gesundheitswesens, [...] Read more.

Dr. Alphons Beat Schnyder ist als Betriebswirtschafter, Experte für Unternehmenskultur und Mitglied der Verwaltungsräte des Spitals STS (Simmental-Thun-Saanenland) und der Triaplus (Integrierte Psychiatrie Uri, Schwyz und Zug) sowie als Referent im Masterprogramm «Health Management» der Hochschule für Wirtschaft ausgewiesener Kenner des Schweizerischen Gesundheitswesens, insbesondere der psychiatrischen Versorgung [...] Full article

1375 KB

Open AccessCase Report

Needle in a haystack—a case of functional eye convergence insufficiency

by Indrit Bègue, Horace Massa, Heimo Steffen and Markus Gschwind

Swiss Arch. Neurol. Psychiatry Psychother. 2018, 169(6), 185-189; https://doi.org/10.4414/sanp.2018.00613 - 1 Jan 2018

Viewed by 78

Abstract

Little is known about functional eye movement disorders (FEMDs). We present the case of a patient who was brought to the emergency department after an episode of unexplained loss of consciousness followed by horizontal diplopia in any gaze direction, and who was finally [...] Read more.

Little is known about functional eye movement disorders (FEMDs). We present the case of a patient who was brought to the emergency department after an episode of unexplained loss of consciousness followed by horizontal diplopia in any gaze direction, and who was finally diagnosed with functional convergence insufficiency after meticulous work-up. The purpose of this case report is to recall a rare presentation of a FEMD to neurologists, psychiatrists and ophthalmologists. This case illustrates the importance of knowledge about FEMDs in the neurological clinic and of close interdisciplinary collaboration, in order to address the patient’s problem as efficiently as possible without detours. Full article

► Show Figures

Figure 1

130 KB

Open AccessReview

Rehabilitation in progressive multiple sclerosis

by Michael Haupts and Dietmar Seidela

Swiss Arch. Neurol. Psychiatry Psychother. 2018, 169(6), 183-184; https://doi.org/10.4414/sanp.2018.00592 - 1 Jan 2018

Cited by 1 | Viewed by 116

Abstract

Probably half of the multiple sclerosis (MS) patients worldwide have progressive MS (PMS) and seek therapy beyond prevention of inflammatory bouts. Therapy plans in PMS have to focus on improvement of abilities in individual problem constellations. Standardized assessment methods in MS beyond the [...] Read more.

Probably half of the multiple sclerosis (MS) patients worldwide have progressive MS (PMS) and seek therapy beyond prevention of inflammatory bouts. Therapy plans in PMS have to focus on improvement of abilities in individual problem constellations. Standardized assessment methods in MS beyond the expanded disability status scale (EDSS) have been developed. Recent studies show positive effects for activating therapies in immobile MS patients. Fair evidence exists for several nonpharmacological therapies. Some data indicate activation of neurotrophic factors and neuroplasticity during therapy. Few medication strategies including corticoid pulses are at hand for PMS. Combined pharmacological and multimodal symptomatic approaches promise increased efficacy. Complex inpatient therapy schemes may be of special value for severely affected patients. Full article

114 KB

Open AccessReview

Supported Employment und die Schweiz

by Holger Hoffmann and Dirk Richter

Swiss Arch. Neurol. Psychiatry Psychother. 2018, 169(6), 181-182; https://doi.org/10.4414/sanp.2018.00601 - 1 Jan 2018

Viewed by 76

Abstract

Supported Employment – and Switzerland. Introducing “supported employment” (SE) for the vocational reintegration of people with severe mental illness in a free market economy led to a paradigm shift in the USA and in Europe. Even though SE is in Switzerland generally [...] Read more.

Supported Employment – and Switzerland. Introducing “supported employment” (SE) for the vocational reintegration of people with severe mental illness in a free market economy led to a paradigm shift in the USA and in Europe. Even though SE is in Switzerland generally the first choice in Switzerland, there is still potential for development and improvement in its implementation. Full article

250 KB

Open AccessReview

In der Schweiz lebende Minderjährige mit Fluchterfahrungen

by Fana Asefaw, Clara Bombach and Lars Wöckel

Swiss Arch. Neurol. Psychiatry Psychother. 2018, 169(6), 171-180; https://doi.org/10.4414/sanp.2018.00605 - 1 Jan 2018

Cited by 3 | Viewed by 94

Abstract

Children and adolescents with refugee experiences. The number of accompanied and unaccompanied minor asylum seekers in Switzerland has increased in recent years. Numerous studies, mostly from abroad, show that children and adolescents with refugee experiences are at high risk of mental illness. [...] Read more.

Children and adolescents with refugee experiences. The number of accompanied and unaccompanied minor asylum seekers in Switzerland has increased in recent years. Numerous studies, mostly from abroad, show that children and adolescents with refugee experiences are at high risk of mental illness. Events in their country of origin, the escape itself and the adjustment to the country of arrival can be associated with traumatic experiences and impede the mobilisation of resources. This article focuses on the housing of children and adolescents who have experienced displacement in the country of arrival and shows, using various examples and with regard to current international research, that the housing of children, adolescents and their families often does not take place in a way that is appropriate to their needs and age. Some stress factors in the country of arrival can represent a high psychosocial burden and a challenge for integration. Participation in social life is hindered for new arrivals in many regards. Accompanied and unaccompanied minor asylum seekers are evidently equally affected by stress and risk factors. Resources can be activated through suitable support measures and targeted integration measures. Full article

141 KB

Open AccessReview

Offene Turen in der Akutbehandlung von Abhangigkeitserkrankungen

by Marc Vogel and Benedikt Habermeyer

Swiss Arch. Neurol. Psychiatry Psychother. 2018, 169(6), 167-170; https://doi.org/10.4414/sanp.2018.00597 - 1 Jan 2018

Cited by 1 | Viewed by 79

Abstract

Open doors in the acute treatment of substance dependence. The concept of “open doors” in in-patient psychiatry has fortunately increased in relevance in German-speaking regions in recent years. Although there is only little evidence supporting treatment in closed wards, this approach is [...] Read more.

Open doors in the acute treatment of substance dependence. The concept of “open doors” in in-patient psychiatry has fortunately increased in relevance in German-speaking regions in recent years. Although there is only little evidence supporting treatment in closed wards, this approach is often pursued in the management of substance dependence as to avoid relapse or treatment discontinuation. Based on current literature, however, it cannot be deduced that this restrictiveapproach benefits patients or the course of treatment. There are even indications that closed treatment might be associated with negative effects. Although study results remain unsatisfactory and methodologically clean studies are urgently required, this context does not justify continuing the treatment of substance dependence in a closed setting. Full article

88 KB

Open AccessEditorial

Eine Schatztruhe und Fundgrube der deutschsprachigen Nervenheilkunde: Auf den Schultern von Riesen

by Jürg Kesselring

Swiss Arch. Neurol. Psychiatry Psychother. 2018, 169(6), 166; https://doi.org/10.4414/sanp.2018.00614 - 1 Jan 2018

Viewed by 80

Abstract

Die Arbeit in unserem SANP wird unter anderem durch seine Geschichte so faszinierend [...] Full article

Journal Menu

Journal Browser

Swiss Arch. Neurol. Psychiatry Psychother., Volume 169, Issue 6 (01 2018) – 10 articles

Further Information

Guidelines

MDPI Initiatives

Follow MDPI